UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 88

Sortiert nach

Mitochondrial dysfunction and pulmonary hypertension: cause, effect, or both

American journal of physiology. Lung cellular and molecular physiology, 2018-05, Vol.314 (5), p.L782-L796

2018

Volltextzugriff (PDF)

Reply: Oral Treprostinil Combination Trials Post Hoc Secondary Analyses: A Step toward Verifying Its Efficacy

American journal of respiratory and critical care medicine, 2016-06, Vol.193 (12), p.1437-1438

Fares, Wassim H

2016

Volltextzugriff (PDF)

Primary cardiac hospitalizations in pulmonary arterial hypertension: Trends and outcomes from 2001 to 2014

Respiratory medicine, 2020-01, Vol.161, p.105850-105850, Article 105850

2020

Volltextzugriff (PDF)

Orenitram . . . not verified

American journal of respiratory and critical care medicine, 2015-03, Vol.191 (6), p.713-714

Fares, Wassim H

2015

Volltextzugriff (PDF)

Pulmonary hypertension: diagnostic and therapeutic challenges

Therapeutics and clinical risk management, 2015-01, Vol.11, p.1221-1233

2015

Volltextzugriff (PDF)

Pulmonary hypertension in patients with interstitial lung disease

Pulmonary pharmacology & therapeutics, 2018-06, Vol.50, p.38-46

2018

Volltextzugriff (PDF)

The 'availability' bias: underappreciated but with major potential implications

Critical care (London, England), 2014-03, Vol.18 (2), p.118-118

Fares, Wassim H

2014

Volltextzugriff (PDF)

Review of the Ongoing Story of Appetite Suppressants, Serotonin Pathway, and Pulmonary Vascular Disease

The American journal of cardiology, 2016-05, Vol.117 (10), p.1691-1696

2016

Volltextzugriff (PDF)

Pushing the Envelope on the Indications and Doses of Pulmonary Arterial Hypertension Medications: What Is Reasonable?

Journal of cardiovascular pharmacology, 2016-04, Vol.67 (4), p.319-321

Fares, Wassim H

2016

Volltextzugriff (PDF)

Hospitalizations with hereditary hemorrhagic telangiectasia and pulmonary hypertension in the United States from 2000 to 2014

Respiratory medicine, 2019-02, Vol.147, p.26-30

2019

Volltextzugriff (PDF)

Hypercoagulability in Pulmonary Hypertension

Clinics in chest medicine, 2018-09, Vol.39 (3), p.595-603

2018

Volltextzugriff (PDF)

Finally, Progress in Pulmonary Hypertension Associated with Heart Failure with Preserved Ejection Fraction

American journal of respiratory cell and molecular biology, 2017-04, Vol.56 (4), p.421-422

2017

Volltextzugriff (PDF)

Netrin‐1 Regulates Fibrocyte Accumulation in the Decellularized Fibrotic Sclerodermatous Lung Microenvironment and in Bleomycin‐Induced Pulmonary Fibrosis

Arthritis & rheumatology (Hoboken, N.J.), 2016-05, Vol.68 (5), p.1251-1261

2016

Volltextzugriff (PDF)

Pulmonary hypertension in obstructive sleep apnea: is it clinically significant? A critical analysis of the association and pathophysiology

Pulmonary Circulation, 2015-06, Vol.5 (2), p.220-227

2015

Volltextzugriff (PDF)

Amiodarone and the risk of cancer: A nationwide population‐based study

Cancer, 2013-11, Vol.119 (22), p.4051-4051

Fares, Wassim H.

2013

Volltextzugriff (PDF)

Pulmonary Hypertension Prevalence and Prognosis in a Cohort of Patients with Hereditary Hemorrhagic Telangiectasia Undergoing Embolization of Pulmonary Arteriovenous Malformations

American journal of respiratory and critical care medicine, 2017-11, Vol.196 (10), p.1353-1356

2017

Volltextzugriff (PDF)

Chronic Right Heart Failure: Expanding Prevalence and Challenges in Outpatient Management

Heart failure clinics, 2018-07, Vol.14 (3), p.413-423

2018

Volltextzugriff (PDF)

The other vascular beds in pulmonary arterial hypertension. Surrogates or associated?

Annals of the American Thoracic Society, 2014-05, Vol.11 (4), p.596-597

Fares, Wassim H

2014

Volltextzugriff (PDF)

Management of Right Heart Failure in the Intensive Care Unit

Clinics in chest medicine, 2015-09, Vol.36 (3), p.511-520

2015

Volltextzugriff (PDF)

Not all catheter-days are equal

Critical care medicine, 2013-02, Vol.41 (2), p.e14-e14

Fares, Wassim H

2013

Volltextzugriff (PDF)

Endovascular Treatment of a Large Iliac Vein Aneurysm and High-Flow Arteriovenous Fistula

Annals of vascular surgery, 2018-11, Vol.53, p.266.e5-266.e7

2018

Volltextzugriff (PDF)

PECAM-1 is Associated WithOutcomes and Response to Treatment in Pulmonary Arterial Hypertension

The American journal of cardiology, 2020-07, Vol.127, p.198-199

2020

Volltextzugriff (PDF)

Plexin C1 deficiency permits synaptotagmin 7–mediated macrophage migration and enhances mammalian lung fibrosis

The FASEB journal, 2016-12, Vol.30 (12), p.4056-4070

2016

Volltextzugriff (PDF)

Pulmonary arterial hypertension in the setting of scleroderma is different than in the setting of lupus: A review

Respiratory medicine, 2018-01, Vol.134, p.42-46

2018

Volltextzugriff (PDF)

Venous Thromboembolism: An Evolving Entity

Clinics in chest medicine, 2018-09, Vol.39 (3), p.xv-xvi

2018

Volltextzugriff (PDF)

1 – 25 von 88

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(76)
Mit Volltextzugriff
(79)

Publikationsform

Artikel
(87)
Buchkapitel
(1)

Sprache

Englisch
(88)
Japanisch
(7)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Mitochondrial dysfunction and pulmonary hypertension: cause, effect, or both

Reply: Oral Treprostinil Combination Trials Post Hoc Secondary Analyses: A Step toward Verifying Its Efficacy

Primary cardiac hospitalizations in pulmonary arterial hypertension: Trends and outcomes from 2001 to 2014

Orenitram . . . not verified

Pulmonary hypertension: diagnostic and therapeutic challenges

Pulmonary hypertension in patients with interstitial lung disease

The 'availability' bias: underappreciated but with major potential implications

Review of the Ongoing Story of Appetite Suppressants, Serotonin Pathway, and Pulmonary Vascular Disease

Pushing the Envelope on the Indications and Doses of Pulmonary Arterial Hypertension Medications: What Is Reasonable?

Hospitalizations with hereditary hemorrhagic telangiectasia and pulmonary hypertension in the United States from 2000 to 2014

Hypercoagulability in Pulmonary Hypertension

Finally, Progress in Pulmonary Hypertension Associated with Heart Failure with Preserved Ejection Fraction

Netrin‐1 Regulates Fibrocyte Accumulation in the Decellularized Fibrotic Sclerodermatous Lung Microenvironment and in Bleomycin‐Induced Pulmonary Fibrosis

Pulmonary hypertension in obstructive sleep apnea: is it clinically significant? A critical analysis of the association and pathophysiology

Amiodarone and the risk of cancer: A nationwide population‐based study

Pulmonary Hypertension Prevalence and Prognosis in a Cohort of Patients with Hereditary Hemorrhagic Telangiectasia Undergoing Embolization of Pulmonary Arteriovenous Malformations

Chronic Right Heart Failure: Expanding Prevalence and Challenges in Outpatient Management

The other vascular beds in pulmonary arterial hypertension. Surrogates or associated?

Management of Right Heart Failure in the Intensive Care Unit

Not all catheter-days are equal

Endovascular Treatment of a Large Iliac Vein Aneurysm and High-Flow Arteriovenous Fistula

PECAM-1 is Associated WithOutcomes and Response to Treatment in Pulmonary Arterial Hypertension

Plexin C1 deficiency permits synaptotagmin 7–mediated macrophage migration and enhances mammalian lung fibrosis

Pulmonary arterial hypertension in the setting of scleroderma is different than in the setting of lupus: A review

Venous Thromboembolism: An Evolving Entity

Suchergebnisse filtern